Searched for
THIERRY VOLLE
Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...- Lupin subsidiary acquires 9 brands South African firmLupin's subsidiary, in partnership with ImpiloVest, has acquired nine brands from MNI in South Africa, enhancing its portfolio in complemen...
- Lupin to acquire French firm Medisol for around Rs 160 crPharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...
- Lupin's arm gets UK regulator nod for COPD treatmentGlobal pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the...
- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...
- Buy Lupin Ltd. target Rs 1470.0 : Sumeet BagadiaBuy Lupin Ltd. at a price target of Rs 1470.0 and a stoploss at Rs 1400.0 from entry point
- Lupin appoints Thierry Volle as President of EMEA businessDrug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...
Load More